Orgenesis Inc Net Income per Employee (ORGS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Orgenesis Inc   (ORGS)
 

Orgenesis Inc Net Income per Employee

ORGS's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 207.66% in the fourth quarter 2024, year on year to cumulative value of $49 million, and with 146 employees, Orgenesis Inc 's income per employee grew on trailing twelve month basis to $ 335,705. The income per employee at Orgenesis Inc ' was above the company average.
The Healthcare sector has seen employees of 19 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 340, from total ranking in previous quarter at 413.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ORGS Net Income per Employee (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Net Income Change 207.66 % 148.75 % -69.97 % -57.2 % 420.68 %
Net Income per Employee (TTM) $ 335,705 241,507 203,555 353,055 444,644
ORGS's Total Ranking # 340 # 413 # 0 # 185 # 0
Seq. Net Income Change 119.9 % -1.07 % -6.39 % 51.06 % 77.8 %

ORGS Company Profile >> Back to ORGS Efficiency Comparisons >> Compare ORGS Net Income per Employee to its Competitors

ORGS Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 20
Healthcare Sector # 32
Overall Market # 340

Net Income per Employee Statistics
High Average Low
$ 444,644 $ 105,122 $ -393,377
(Dec 31 2023)   (Mar 31 2020)




  News about Orgenesis Inc Income per employee

Orgenesis Consortium Secures 2.0M EUR Grant from Walloon Government to Revolutionize Decentralized ATMP Manufacturing with AI

Orgenesis Consortium Awarded 2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
GERMANTOWN, Md., Feb. 29, 2024 - Orgenesis Inc. (Nasdaq:ORGS), the world-renowned global leader in decentralized cell and gene therapies (CGTs), proudly announces that its consortium has been honored with a significant 2.0 million euro grant from the esteemed Walloon Government in Belgium. This prestigious grant,




Companies with similar Income per Employee for 12 month ending Dec 31 2024, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2024Number of Employees Dec 31 2024
Interpace Biosciences Inc   524,294.12 $ 53.478  Million 102 
Harmony Biosciences Holdings inc   496,563.14 $ 145.493  Million 293 
Polypid Ltd  491,898.31 $ 29.022  Million 59 
Cytomx Therapeutics Inc   461,869.57 $ 31.869  Million 69 
Nutriband Inc   440,270.00 $ 2.201  Million 5 
Addex Therapeutics Ltd  415,046.29 $ 7.056  Million 17 
Amgen Inc   314,615.38 $ 4,090.000  Million 13,000 
Adma Biologics Inc   305,522.41 $ 197.673  Million 647 
Krystal Biotech Inc   302,233.90 $ 89.159  Million 295 
Semnur Pharmaceuticals Inc   289,596.76 $ 11.005  Million 38 
Regeneron Pharmaceuticals Inc   286,346.53 $ 4,412.600  Million 15,410 
Acadia Pharmaceuticals Inc   283,773.18 $ 226.451  Million 798 
Sarepta Therapeutics Inc   281,723.35 $ 235.239  Million 835 
Kiora Pharmaceuticals Inc   276,517.92 $ 3.595  Million 13 
Lantheus Holdings Inc   261,896.06 $ 312.442  Million 1,193 
Edwards Lifesciences Corporation  260,606.25 $ 4,169.700  Million 16,000 
Dariohealth Corp   259,072.73 $ 42.747  Million 165 
Promis Neurosciences inc   252,624.82 $ 2.779  Million 11 
Puretech Health Plc  235,440.68 $ 27.782  Million 118 
Merck and Co Inc   228,440.00 $ 17,133.000  Million 75,000 
Galapagos Nv  227,320.11 $ 82.972  Million 365 
Carlisle Companies Incorporated  222,338.98 $ 1,311.800  Million 5,900 
Biogen Inc   217,626.67 $ 1,632.200  Million 7,500 
Eli Lilly And Company  211,800.00 $ 10,590.000  Million 50,000 
Minerva Neurosciences Inc   205,552.14 $ 1.439  Million 7 
Coherus Oncology inc   193,925.17 $ 28.507  Million 147 
Jazz Pharmaceuticals Plc  193,813.15 $ 560.120  Million 2,890 
Corcept Therapeutics Inc  191,415.07 $ 139.733  Million 730 
Alkermes Plc   179,058.54 $ 367.070  Million 2,050 
Zoetis Inc   172,137.93 $ 2,496.000  Million 14,500 


Date modified: 2026-06-22T14:32:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.